Duration of humoral response to the third dose of BNT162b2 vaccine in patients with solid cancer: Is fourth dose urgently needed?

Saved in:
Bibliographic Details
Title: Duration of humoral response to the third dose of BNT162b2 vaccine in patients with solid cancer: Is fourth dose urgently needed?
Authors: Di Noia, Vincenzo1 (AUTHOR) vincenzo.dinoia@ifo.it, Pimpinelli, Fulvia2 (AUTHOR), Renna, Davide1 (AUTHOR), Campo, Flaminia3 (AUTHOR), Cosimati, Antonella4 (AUTHOR), Torchia, Andrea4 (AUTHOR), Marcozzi, Benedetta5 (AUTHOR), Massacci, Alice5 (AUTHOR), Pallocca, Matteo5 (AUTHOR), Pellini, Raul3 (AUTHOR), Morrone, Aldo6 (AUTHOR), Cognetti, Francesco7 (AUTHOR)
Source: European Journal of Cancer. Nov2022, Vol. 176, p164-167. 4p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/j.ejca.2022.09.006